Quarterly report pursuant to Section 13 or 15(d)

Equity (Details 1)

Equity (Details 1) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Number of shares
Granted	0	0
Exercised	0	0
Warrants [Member]
Number of shares
Warrants outstanding, beginning balance	77	77
Granted
Exercised
Warrants outstanding, ending balance	77	77
Warrants exercisable, beginning balance		77
Warrants exercisable, ending balance	77
Weighted Average Exercise Price Per Share
Weighted Average Exercise Price Per Share warrants outstanding, beginning balance	$ 2.00	$ 2.00
Weighted Average Exercise Price Per Share Warrants outstanding, ending balance	2.00	2.00
Weighted Average Exercise Price Per Share Warrants exercisable, beginning balance	2.00	2.00
Weighted Average Exercise Price Per Share Warrants exercisable, ending balance	$ 2.00	$ 2.00
Weighted Average Remaining Contractual Life
Weighted Average Remaining Contractual Life Warrants outstanding, beginning balance	4 years 2 months 30 days	4 years 5 months 30 days
Weighted Average Remaining Contractual Life Warrants outstanding, ending balance	4 years 3 days	4 years 2 months 30 days
Weighted Average Remaining Contractual Life Warrants exercisable, beginning balance		4 years 5 months 30 days
Weighted Average Remaining Contractual Life Warrants exercisable, ending balance	4 years 3 days
Total Intrinsic Value of Warrants
Total Intrinsic Value of Warrants Warrants outstanding, beginning balance	$ 0	$ 0
Total Intrinsic Value of Warrants,Warrants outstanding, ending balance	0	0
Total Intrinsic Value of Warrants Warrants exercisable, beginning balance	0	0
Total Intrinsic Value of Warrants Warrants exercisable, ending balance	$ 0	$ 0